A qualitative evaluation of clinical services under the Community Pharmacy Contractual Framework
ResearchPublished Jul 14, 2025
A qualitative evaluation exploring how CPCF clinical services are implemented in England's community pharmacies. Pharmacies found to offer accessible, trusted care but face financial strain, limited integration, and low public awareness. Future commissioning must reflect the evolving role of pharmacists and today's economic and policy landscape.
ResearchPublished Jul 14, 2025
Community pharmacies in England are an integral part of the healthcare system. In February 2024, RAND Europe was commissioned by NHS England to conduct a qualitative evaluation of some clinical services provided in community pharmacies under the Community Pharmacy Contractual Framework (CPCF) five-year deal (2019-2024). The purpose of this qualitative evaluation was to understand the implementation of CPCF clinical services and to inform future planning and rollout of these services. The evaluation included the voices of more than 100 stakeholders, from diverse areas of England, representing community pharmacies, integrated care boards, primary care networks, local pharmaceutical committees, and members of the public. This evaluation identified various factors that influence the delivery of CPCF clinical services, including those related to services specifications, pharmacy staff and pharmacy characteristics, service users, relationships with other healthcare professionals, and lastly, the wider health system and national policies. The CPCF five-year deal was established in 2019, within a very different economic landscape than today. Future commissioning of clinical services in community pharmacies must consider this new economic landscape, the evolving professional role of pharmacists, and the NHS 10-Year Health Plan, which aims to shift healthcare focus from hospitals to communities, from sickness to prevention, and from analogue to digital. The potential for community pharmacies to help to shape the future delivery of clinical services in England will depend on how these services are commissioned moving forward.
The research described in this report was prepared for NHS England and conducted by RAND Europe.
This publication is part of the RAND research report series. Research reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND research reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.